Mid-trimester amniocentesis and antibiotic prophylaxis

Prenatal Diagnosis

Volumn 27, Issue 10, 2007, Pages 956-959

  Gramellini, Dandolo ^a,b   Fieni, Stefania ^a   Casilla, Giovanna ^a   Raboni, Stefano ^a   Nardelli, Giovanni Battista ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Antibiotic prophylaxis; Fetal loss; Mid trimester amniocentesis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN;

ADULT; AMNIOCENTESIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; AMNIOCENTESIS; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AZITHROMYCIN; CLAVULANIC ACID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; ITALY; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 35348991118     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1809     Document Type: Article

References (29)

1. Antsaklis A, Papantoniou N, Xygakis A, Mesogitis S, Tzortzis E, Michalas S. 2000. Genetic amniocentesis in women 20-34 years old: associated risks. Prenat Diagn 20(3): 247-250.
2. Ayadi S, Carbillon L, Varlet C, Uzan M, Pourriat JL. 1998. Fatal sepsis due to Escherichia coli after second-trimester amniocentesis. Fetal Diagn Ther 13(2): 98-99.
3. Berg TG, Philpot KL, Welsh MS, Sanger WG, Smith CV. 1999. Ureaplasma/Mycoplasma-infected amniotic fluid. Pregnancy outcome in treated and non treated patients. J Perinatol 19: 275-277.
4. Cassell GH, Davis RO, Waites KB, et al. 1983. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 10: 294-302.
5. Duff P. 1997. Antibiotic selection in obstetric patients. Infect Dis Clin North Am 11(1): 1-12.
6. Esrig SM, Leonardi DE. 1985. Spontaneous abortion after amniocentesis in women with a history of spontaneous abortion. Prenat Diagn 5(5): 321-328.
7. Gerber S, Vial Y, Hohlfeld P, Witkin SS. 2003. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid polymerase chain reaction correlates with subsequent labor and delivery. J Infect Dis 187: 518-521.
8. Gray DJ, Robinson HB, Malone J, Thomson RB Jr. 1992. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 12: 111-117.
9. Hassan S, Romero R, Hendler I, et al. 2006. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 34: 13-19.
10. Heller DS, Moorehouse-Moore C, Skurnick J, Baergen RN. 2003. Second-trimester pregnancy loss at an urban hospital. Infect Dis Obstet Gynecol 11(2): 117-122.
11. Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M. 1995. Infection of amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 40: 375-379.
12. Lettau R, Klink F, Oberheuser F, Marre R. 1986. Bacteriologic studies of the amniotic fluid following amniocentesis. Z Geburtshilfe Perinatol 190(6): 256-260.
13. Marthin T, Liedgren S, Hammar M. 1997. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet Gynecol Scand 76(8): 728-732.
14. McDonald HM, Chambers HM. 2000. Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganism similar to that in preterm labor? Infect Dis Obstet Gynecol 8(5-6): 220-227.
15. Mungen E, Tutuncu L, Muhcu M, Yergok YZ. 2006. Pregnancy outcome following second-trimester amniocentesis: a case-control study. Am J Perinatol 23(1): 25-30.
16. Papantoniou NE, Daskalakis GJ, Tziotis JG, Kitmirides SJ, Mesogitis SA, Antsaklis AJ. 2001. Risk factors predisposing to fetal loss following a second trimester amniocentesis. BJOG 108(10): 1053-1056.
17. Perni SC, Vardhana S, korneeva I, et al. 2004. Mycoplasma hominis and Ureaplasma urealyticum∼ in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 191: 1382-1386.
18. Plachouras N, Sotiriadis A, Dalkalitsis N, Kontostolis E, Xiropotamos N, Paraskevaidis E. 2004. Fulminant sepsis after invasive prenatal diagnosis. Obstet Gynecol 104: 1244-1247.
19. Romero R, Munoz H, Gomez R, et al. 1995. Two-thirds of spontaneous abortion/fetal deaths after genetic midtrimester amniocentesis are the result of a pre-existing subclinical inflammatory process of the amniotic cavity [abstract]. Am J Obstet Gynecol 172: 261.
20. Royal College of Obstetricians and Gynaecologists. 2005. Amniocentesis and Chorionic Villous Sampling. Guideline No.8. Revised January.
21. Saltvedt S, Almstrom H. 1999. Fetal loss rate after second trimester amniocentesis at different gestational age. Acta Obstet Gynecol Scand 78(1): 10-14.
22. Salvador E, Bienstock J, Blakemore KJ, Pressman E. 2002. Leiomyomata uteri, genetic amniocentesis, and the risk of second-trimester spontaneous abortion. Am J Obstet Gynecol 186(5): 913-915.
23. Straka M, Dela Cruz W, Blackmon C, et al. 2004. Rapid detection of group B streptococcus and Escherichia coli in amniotic fluid using real-time fluorescent PCR. Infect Dis Obstet Gynecol 12(3-4): 109-114.
24. Tebes S, Zakhary AS, Spellacy W. 2005. Escherichia coli septic shock following second-trimester amniocentesis. Fetal Diagn Ther 20(5): 463-464.
25. Thorp JA, Helfgott AW, King EA, King AA, Minyard AN. 2005. Maternal death after second-trimester genetic amniocentesis. Obstet Gynecol 105: 1213-1215.
26. Vesce F, Buzzi M, Ferretti ME, et al. 1998. Inhibition of amniotic prostaglandin E release by ampicillin. Am J Obstet Gynecol 178(4): 759-764.
27. Vesce F, Pavan B, Buzzi M, et al. 1999. Effect of different classes of antibiotics on amniotic prostaglandin E release. Prostaglandins Other Lipid Mediat 57(4): 207-218.
28. Vesce F, Pavan B, Lunghi L, et al. 2004. Inhibition of amniotic interleukin-6 and prostaglandin E2 release by ampicillin. Obstet Gynecol 103(1): 108-113.
29. Wenstrom KD, Andrews WW, Tamura T, Du Bard MB, Johnston KE, Hemstreet GP. 1996. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 175: 830-833.